Says it sees supply of 1.3bn doses by the end of 2021
– 100m doses this year upon approval
– showed strong immunogenicity in younger, older adults
– vaccine well tolerated across all populations

Continue Reading:…

Search Web: Pfizer says its COVID-19 vaccine is on track to seek regulatory review in October

Recent Posts

Leave a Reply

Your email address will not be published. Required fields are marked *